Gemcitabine Hydrochloride for Injection 0.2g

• Customization: Available
• Package: 1vial/Box
• Composition: Gemcitabine Hydrochloride
• Model NO.: 0.2g
• Transport Package: Free
• Specification: 0.2g/vial
• Trademark: Sinolead
• Origin: China

Product Description

Product	Dose	Package
Gemcitabine Hydrochloride For Injection	0.2g	1vial/box

• Gemcitabine Hydrochloride for Injection (200 mg) is a nucleoside analog used as a chemotherapy agent, which works by interfering with DNA synthesis, ultimately leading to cancer cell death. It is commonly used in the treatment of several types of cancers.

Indications:
 

Gemcitabine is indicated for:

• Non-Small Cell Lung Cancer (NSCLC): Often used in combination with cisplatin.
• Pancreatic Cancer: As a single agent for locally advanced or metastatic cases.
• Breast Cancer: Typically used with paclitaxel for locally advanced or metastatic cases.
• Bladder Cancer: Used with cisplatin for advanced or metastatic cases.

Administration:

• Infusion: Administer as an intravenous infusion over 30 minutes. Longer infusions can increase the risk of toxicity.
• Line Flush: Ensure the IV line is flushed before and after gemcitabine infusion to avoid mixing with other drugs.

Precautions:

• Blood Counts: Monitor frequently to detect any hematologic toxicities early.
• Renal and Liver Function: Adjustments may be necessary in patients with impaired kidney or liver function.
• Pregnancy and Breastfeeding: Contraindicated as it may harm the fetus or infant.
• Hydration: Encourage adequate fluid intake to help with renal clearance of the drug.